NCT06839456: Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 100 planned
- Started
- 21 Mar 2025
- Primary completion
- Mar 2031
- Arms
- Phase 2:TCRab/CD19 depleted PSCT with CD45RA depleted addback using unrelated donors
- Results
- None posted
- 21 Feb 2025: Trial registered
- 21 Mar 2025: Trial started